| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $2.61K | +100 | +0.01% | $26.10 | 668K | Feb 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$13.7K | -100 | -0.01% | $137.29 | 668K | Feb 7, 2022 | Direct | F1, F2 |
| transaction | SGEN | Common Stock | Options Exercise | $93.3K | +3.57K | +0.54% | $26.10 | 672K | Feb 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$497K | -3.57K | -0.53% | $138.97 | 668K | Feb 7, 2022 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $235K | +8.99K | +1.35% | $26.10 | 677K | Feb 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$1.26M | -8.99K | -1.33% | $139.96 | 668K | Feb 7, 2022 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Options Exercise | $107K | +4.08K | +0.61% | $26.10 | 672K | Feb 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$575K | -4.08K | -0.61% | $140.83 | 668K | Feb 7, 2022 | Direct | F1, F2, F5 |
| transaction | SGEN | Common Stock | Options Exercise | $7.83K | +300 | +0.04% | $26.10 | 668K | Feb 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$42.5K | -300 | -0.04% | $141.56 | 668K | Feb 7, 2022 | Direct | F1, F2, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -100 | -0.08% | $0.00 | 119K | Feb 7, 2022 | Common Stock | 100 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -3.57K | -3% | $0.00 | 116K | Feb 7, 2022 | Common Stock | 3.57K | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -8.99K | -7.77% | $0.00 | 107K | Feb 7, 2022 | Common Stock | 8.99K | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -4.08K | -3.83% | $0.00 | 103K | Feb 7, 2022 | Common Stock | 4.08K | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -300 | -0.29% | $0.00 | 102K | Feb 7, 2022 | Common Stock | 300 | $26.10 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $138.36 to $139.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $139.36 to $140.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $140.36 to $141.32. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Reflects sales of common stock executed in multiple transactions at prices ranging from $141.40 to $141.78. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F7 | Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16. |